EMERGING ANTIMICROBIALS AND DIAGNOSTICS in AMR: 26/27 NOV 2024

Search for:

Home » _News » Smart Innovations » Page 12

AMR news related to Smart Innovations

For Scientists, Researchers and Innovating Professionals who want to stay adequately informed on Antimicrobial resistance, AMR Insights offers the most comprehensive overview of recently published, global news and information.

Polypharmakos and CABI to develop new antimicrobial products from CABI Culture Collection

CARB-X IS FUNDING AUSTRALIAN-BIOTECH SPEEDX TO DEVELOP A RAPID POINT-OF-CARE DIAGNOSTIC FOR SEXUALLY TRANSMITTED DISEASES CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE

Successful Use of Telemedicine Infectious Diseases Consultation with an Antimicrobial Stewardship-Led Staphylococcus aureus Bacteremia Care Bundle

More than 60 U.S. lawmakers urge House appropriators for more funds to address antimicrobial resistance

Discovery may help boost peptide design

The hidden pandemic: Innovate UK welcomes the global AMR community

Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection

Discovery That Antibiotic “Pops” Bacteria Could Lead to Improved Treatments for Superbugs

Robotic Antimicrobial Susceptibility Platform (RASP): a next-generation approach to One Health surveillance of antimicrobial resistance

IIT Madras and U.K. Researchers Develop Paper-based Sensor to detect Antimicrobial Resistance triggering Pollutants

BGU researchers develop antibiotic tweezers to battle resistant bacteria

‘Last resort’ antibiotic pops bacteria like balloons

Treating antibiotic resistance: Need for diagnostics and AI

Medicines in Development for Antimicrobial Resistance (AMR) 2021 Report

New PhRMA Report Shows Nearly 90 Medicines in Development to Fight Drug-Resistant Infections, but Future Pipeline Remains Challenging

Pfizer buys Amplyx to expand drug-resistant treatment portfolio

X-BIOTIX THERAPEUTICS ANNOUNCES CHANGE IN CORPORATE STRATEGY

CARB-X IS FUNDING UK-BIOTECH GENOMEKEY TO DEVELOP A RAPID DIAGNOSTIC FOR SEPSIS, A LEADING CAUSE OF DEATH IN HOSPITALS

Lack of Funding Drives Biotech to Suspend Drug-Resistant Antibiotic Pipeline

“We Don’t Just Need a Few New Antibiotics, We Need an Arsenal”

Antibiotic development, stewardship advocates see window of opportunity

2020 antibacterial agents in clinical and preclinical development: an overview and analysis

CARB-X IS FUNDING PHICO THERAPEUTICS TO DEVELOP AN ENGINEERED BACTERIOPHAGE DRUG TO TREAT VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA

BioVersys receives €20 million in EU financing to support development of new antibiotics

Superbug killer: New nanotech destroys bacteria and fungal cells

JPIAMR project dashboard published

CARB-X IS FUNDING NOVEL MICRODEVICES TO DEVELOP A RAPID AND PORTABLE DIAGNOSTIC FOR SEXUALLY TRANSMITTED DISEASES INCLUDING ANTIBIOTIC-RESISTANT INFECTIONS

From Treatment Options to Precision Medicine: The Future of “Omics-Based” Antibiotic Resistance Surveillance Data

Culture-Independent Genotyping, Virulence and Antimicrobial Resistance Gene Identification of Staphylococcus aureus from Orthopaedic Implant-Associated Infections

New ReAct report: Governments need to take more leadership to ensure global sustainable access to effective antibiotics

Oxford vaccine team wins £1.4m to develop jab against ‘super gonorrhoea’

Now Britain’s genome-busters use Covid success to target superbugs

Groups urge Congress to boost funding for AMR, antibiotic development

Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence

Indian Priority Pathogen List jointly developed by DBT and WHO India Office

Practical nanozymes discovered to fight antimicrobial resistance

Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria

NIH awards grants to support bacteriophage therapy research

Chemically modified and conjugated antimicrobial peptides against superbugs

New model can predict how bacteria develop antibiotic resistance

Antibiotics Currently in Global Clinical Development (update)

AMR Fund and Global Cohorts Working to Prevent Another Pandemic

Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates

Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations

Identification of Antimicrobial Resistance Mechanism May Lead to Novel Drug Targets

AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic

Looking for Solutions to the Pitfalls of Developing Novel Antibacterials in an Economically Challenging System

Tracking the Pipeline of Antibiotics in Development

CARB-X IS FUNDING AFFINIVAX TO DEVELOP A NOVEL VACCINE TO PREVENT STAPHYLOCOCCUS AUREUS BACTERIAL INFECTIONS

Research pinpoints unique drug target in antibiotic resistant bacteria

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed